REYNA VALLE MARISCAL: Open Payments
NPI 1689221483 · CERES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,414 in 135 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $962 · 2025 $2,414
Food & beverage: $2,314Education: $100
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 16 | $399 |
| Janssen Biotech, Inc. | 19 | $317 |
| Lilly USA, LLC | 17 | $293 |
| Regeneron Healthcare Solutions, Inc. | 9 | $219 |
| Arcutis Biotherapeutics, Inc. | 18 | $210 |
| Incyte Corporation | 18 | $205 |
| GENZYME CORPORATION | 8 | $191 |
| ABBVIE INC. | 14 | $176 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| PFIZER INC. | 3 | $80 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, TALTZ, Zoryve, OPZELURA, SKYRIZI, COSENTYX.
Industry payments across CA — which companies pay providers there.
